Association of the Myeloperoxidase polymorphism with the risk of gastric cancer

Anticancer Research

Volumn 28, Issue 2 B, 2008, Pages 1317-1323

  Hsu, Ping I ^a,g   Jwo, Jyh Jen ^b   Yang, Chia Lin ^b   Hsu, Ping Ning ^c   Yang, Hsiao Bai ^d   Lai, Kwok Hung ^a   Chen, I Shu ^a   Chuah, Seng Kee ^e   Wu, Deng Chyang ^b,f   Chen, Angela ^b  

^a KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d Ton Yen General Hospital   (Taiwan)

^e CHANG GUNG UNIVERSITY   (Taiwan)

^f KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^g NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Gastric cancer; Gastritis; Helicobacter pylori; Myeloperoxidase; Neutrophil; Polymorphism

Indexed keywords

MYELOPEROXIDASE;

AGED; ALLELE; ARTICLE; CANCER PATIENT; CANCER RISK; CONTROLLED STUDY; ENZYME POLYMORPHISM; FEMALE; GENOTYPE; HELICOBACTER INFECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL; STOMACH CANCER; STOMACH MUCOSA;

AGED; CASE-CONTROL STUDIES; FEMALE; GASTRITIS; GENETIC PREDISPOSITION TO DISEASE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; PEROXIDASE; POLYMORPHISM, SINGLE NUCLEOTIDE; STOMACH NEOPLASMS;

EID: 42549101282     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N and Schlemper RJ: Helicobacter infection and the development of gastric cancer. N Engl J Med 345: 784-789, 2001.
2. Hsu PI, Lai KH, Hsu PN, Lo GH, Yu HC, Chen WC, Tsay FW, Lin HC, Tseng HH, Ger LP and Chen HC: Helicobacter pylori infection and the risk of gastric malignancy. Am J Gastroenterol 102: 1-6, 2007.
3. Hsu PI, Lai KH, Lo GH, Tseng HH, Lo CC, Chen HC, Tsai WL, Jou HS, Peng NJ, Chein CH, Chen JL and Hsu PN: Risk factors for ulcer development in patients with non-ulcer dyspepsia: a prospective two-year follow-up study of 209 patients. Gut 51: 15-20, 2002.
4. Go MF: Natural history and epidemiology of Helicobacter pylori infection. Aliment Pharmacol Ther 16(suppl 1): 3-15, 2002.
5. Kusters JG, van Vliet AH and Kuipers EJ: Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev 19: 449-490, 2006.
6. Blaser MJ, Perez-Perez GI, Kleanthous H, Cover TL, Peek RM, Chyou PH, Stemmermann GN and Nomura A: Infection of Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 55: 2111-2115, 1995.
7. Censini S, Stein M and Covacci A: Cellular responses after induced after contact with Helicobacter pylori. Curr Opin Microbiol 4: 41-46, 2001.
8. Naito Y and Yoshikawa T: Molecular and cellular mechanisms involved in Helicobacter pylori-induced inflammation and oxidative stress. Free Radic Biol Med 33: 323-336, 2001.
9. Yamaoka Y, Kodama T, Gutierrez O, Kim JG, Kashima K and Graham DY: Relationship between Helicobacter pylori iceA, cagA, and vacA status and clinical outcome: studies in four different countries. J Clin Microbiol 37: 2274-2279, 1999.
10. Hsu PI, Hwang IR, Cittelly D, Lai KH, El-Zimaity HMT, Gutierrez O, Kim JG, Osato MS, Graham DY and Yamaoka Y: Clinical presentation in relation to diversity within the Helicobacter pylori cag pathogenicity island. Am J Gastroenterol 97: 2231-2238, 2002.
11. El-Omar EM: Gastric cancer and H. pylori: host genetics open the way. Gastroenterology 21: 1002-1004, 2001.
12. Chen A, Li CN, Hsu PI, Lai KH, Tseng HH, Hsu PN, Lo GH, Lo CC, Lin LK, Hwang IR, Yamaoka Y and Chen HC: Risks of interleukin-1 genetic polymorphisms and Helicobacter pylori infection in the development of gastric cancer. Aliment Pharmacol Ther 20: 203-211, 2004.
13. El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, Young HA, Herrera J, Lissowska J, Yuan CC, Rothman N, Lanyon G, Martin M, Fraumeni JF Jr and Rabkin CS: Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 404: 398-402, 2000.
14. Hampton MB, Kettle AJ and Winterbourn CC: Inside the neutrophil phagosome: oxidants, myeloperoxidase, and bacterial killing. Blood 92: 3007-3017, 1998.
15. Le Marchand L, Seifried A, Lum A and Wilkens LR: Association of the myeloperoxidase -463G→A polymorphism with lung cancer risk. Cancer Epidemiol Biomarkers Prev 9: 181-184, 2000.
16. Piedrafita FJ, Molander RB, Vansant G, Orlova EA, Pfahl M and Reynolds WF: An Alu element in the myeloperoxidase promoter contains a composite SP1-thyroid hormone-retinoid acid response element. J Biol Chem 271: 14412-14420, 1996.
17. Costa RN, Conran N, Albuquerque DM, Soares PH, Saad ST and Costa FF: Association of the G-463A myeloperoxidase polymorphism with infection in sickle cell anemia. Haematologica 90: 977-979, 2005.
18. Rocha V, Franco RF, Porcher R, Bittencourt H, Silva WA Jr, Latouche A, Devergie A, Esperou H, Ribaud P, Socie G, Zago MA and Gluckman E: Host defense and inflammatory gene polymorphisms are associated with outcomes after HLA-identical sibling bone marrow transplantation. Blood 100: 3908-3918, 2002.
19. Roe I, Nam S, Kim J, Shin J, Bang W and Yang M: Association of the myeloperoxidase -463G→A polymorphism with development of atrophy in Helicobacter pylori-infected gastritis. Am J Gastroenterol 97: 1629-1634, 2002.
20. Dally H, Gassner K, Jäger B, Schmezer P, Spiegelhaider B, Edler L, Drings P, Dienemann H, Schulz V, Kayser K, Bartsch H and Risch A: Myeloperoxidase (MPO) genotype and lung cancer histologic types: the MPO -463 A allele is associated with reduced risk for small cell lung cancer in smokers. Int J Cancer 10: 530-535, 2002.
21. Cascorbi I, Henning S, Brockmöller J, Gephart J, Meisel C, Müller JM, Loddenkemper R and Roots I: Substantially reduced risk of cancer of the aerodigestive tract in subjects with variant -463A of the myeloperoxidase gene. Cancer Res 60: 644-649, 2000.
22. Hung RJ, Boffetta P, Brennan P, Malaveille C, Gelatti U, Placidi D, Carta A, Hautefeuille A and Porru S: Genetic polymorphisms of MPO, COMT, MnSOD, NQO1, interaction with environmental exposures and bladder cancer risk. Carcinogenesis 25: 973-978, 2004.
23. Hsu PI, Lai KH, Tseng HH, Lo GH, Lo CC, Lin CK, Cheng JS, Chan HH, Ku MK, Peng NJ, Chien EJ, Chen W and Hsu PN: Eradication of Helicobacter pylori prevents ulcer development in patients with ulcer-like functional dyspepsia. Aliment Pharmacol Ther 15: 195-201, 2001.
24. Dixon MF, Genta RM, Yardley JH and Correa P: Classification and grading of gastritis. The Updated Sydney System. Am J Surg Pathol 20: 1161-1181, 1996.
25. Hsu PI, Lai KH, Tseng HH, Lin CK, Lo GH, Cheng JS, Chan HH, Chen GC, Jou HS, Peng NJ, Ger LP, Chen W and Hsu PN: Risk factors for presentation with bleeding in patients with Helicobacter pylori-related peptic ulcer diseases. J Clin Gastroenterol 30: 386-391, 2000.
26. Hsu PI, Jwo JJ, Tseng HH, Lai KH, Lo GH, Lo CC, Wu CJ, Chuah SK, Hwang IR, Chen JL, Chen YS and Chen A: Association of the myeloperoxidase -468G→A polymorphism with gastric inflammation and duodenal ulcer risk. World J Gastroenterol 11: 2796-2801, 2005.
27. Babior BM: Phagocytes and oxidative stress. Am J Med 109: 33-44, 2000.
28. Hocker M and Hohenberger P: Helicobacter pylori virulence factors - one part of a big picture. Lancet 362: 1231-1233, 2003.
29. Gaut JP, Yeh GC, Tran HD, Byun J, Henderson JP, Richter GM, Brennan ML, Lusis AJ, Belaaouaj A, Hotchkiss RS and Heinecke JW: Neutrophils employ the myeloperoxidase system to generate antimicrobial brominating and chlorinating oxidants during sepsis. Proc Natl Acad Sci USA 98: 11961-11966, 2001.
30. Kensler TW, Egner PA, Moore KG, Taffe BG, Twerdok LE and Trash MA: Roles of inflammatory cells in the metabolic activation of polycyclic aromatic hydrocarbons in mouse skin. Toxicol Appl Pharmacol 90: 337-346, 1987.